These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 28213434)

  • 1. Malaria during Pregnancy.
    Fried M; Duffy PE
    Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28213434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
    Kakuru A; Jagannathan P; Muhindo MK; Natureeba P; Awori P; Nakalembe M; Opira B; Olwoch P; Ategeka J; Nayebare P; Clark TD; Feeney ME; Charlebois ED; Rizzuto G; Muehlenbachs A; Havlir DV; Kamya MR; Dorsey G
    N Engl J Med; 2016 Mar; 374(10):928-39. PubMed ID: 26962728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women.
    Teo A; Randall LM; Madanitsa M; Mwapasa V; Phiri LK; Khairallah C; Buffet C; Karahalios A; Narum DL; Kuile FOT; Rogerson SJ
    Sci Rep; 2019 May; 9(1):7878. PubMed ID: 31133672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.
    Desai M; Gutman J; L'lanziva A; Otieno K; Juma E; Kariuki S; Ouma P; Were V; Laserson K; Katana A; Williamson J; ter Kuile FO
    Lancet; 2015 Dec; 386(10012):2507-19. PubMed ID: 26429700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.
    ter Kuile FO; van Eijk AM; Filler SJ
    JAMA; 2007 Jun; 297(23):2603-16. PubMed ID: 17579229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial.
    Anvikar AR; Kuepfer I; Mishra V; Bruce J; Arya T; Mishra DR; Mohanty S; Mohanty R; Srivastava B; Sharma S; Mishra N; Greenwood B; Chandramohan D; Valecha N
    Malar J; 2018 Jul; 17(1):246. PubMed ID: 29973212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
    Divala TH; Mungwira RG; Mawindo PM; Nyirenda OM; Kanjala M; Ndaferankhande M; Tsirizani LE; Masonga R; Muwalo F; Boudová S; Potter GE; Kennedy J; Goswami J; Wylie BJ; Muehlenbachs A; Ndovie L; Mvula P; Mbilizi Y; Tomoka T; Laufer MK
    Lancet Infect Dis; 2018 Oct; 18(10):1097-1107. PubMed ID: 30195996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
    Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
    BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria in the pregnant woman.
    Duffy PE; Fried M
    Curr Top Microbiol Immunol; 2005; 295():169-200. PubMed ID: 16265891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Kajubi R; Ochieng T; Kakuru A; Jagannathan P; Nakalembe M; Ruel T; Opira B; Ochokoru H; Ategeka J; Nayebare P; Clark TD; Havlir DV; Kamya MR; Dorsey G
    Lancet; 2019 Apr; 393(10179):1428-1439. PubMed ID: 30910321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
    Steketee RW; Wirima JJ; Slutsker L; Roberts JM; Khoromana CO; Heymann DL; Breman JG
    Am J Trop Med Hyg; 1996; 55(1 Suppl):24-32. PubMed ID: 8702034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and control of malaria in pregnancy - new threats, new opportunities?
    Rogerson SJ; Unger HW
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):361-375. PubMed ID: 27973923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
    Chico RM; Chandramohan D
    Trop Med Int Health; 2011 Jul; 16(7):774-85. PubMed ID: 21477099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria.
    White NJ; Pukrittayakamee S; Hien TT; Faiz MA; Mokuolu OA; Dondorp AM
    Lancet; 2014 Feb; 383(9918):723-35. PubMed ID: 23953767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to full-length and the DBL5 domain of VAR2CSA in pregnant women after long-term implementation of intermittent preventive treatment in Etoudi, Cameroon.
    Djontu JC; Lloyd YM; Megnekou R; Seumko'o RMN; Salanti A; Taylor DW; Leke RGF
    PLoS One; 2020; 15(8):e0237671. PubMed ID: 32797068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?
    Gaillard T; Boxberger M; Madamet M; Pradines B
    Malar J; 2018 Dec; 17(1):469. PubMed ID: 30547849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
    Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.